TherML™ integrates CombinAbleAI’s advanced, next generation biologics expertise with insitro’s existing small molecule and oligonucleotide capabilities, unifying therapeutic design across all major ...
WALTHAM, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- ElevateBio, a technology-driven advanced therapy CDMO and gene editing services partner, today announced data from presentations at the American ...
Antibody-drug conjugate (ADC) after ADC: Predicting survival in patients with HER2-low metastatic breast cancer with lung metastasis using artificial intelligence (AI) and radiomics. This is an ASCO ...
Conversation is a well-established diagnostic tool. For disorders such as Parkinson’s disease and amyotrophic lateral sclerosis, patient assessments include interviews during which observations are ...
AI medical imaging market is projected to exceed $20B by 2035. Generative models address class imbalances in medical imaging ...